Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03195179 · ClinicalTrials.gov registry record
Primary Urethral Realignment Versus Suprapubic Cystostomy After Pelvic Fracture Urethral Injury
A clinical trial, sponsored by University of Utah.
- Completed
- Registry status
- 200
- Enrollment target
NCT03195179: Completed study, sponsored by University of Utah.
NCT03195179 is a clinical trial that has completed, run by University of Utah. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03195179 has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
Pelvic fracture urethral injuries (PFUI) occur in up to 10% of pelvic fractures. It remains controversial whether initial urethral realignment after PFUI decreases rates of urethral obstruction and the need for subsequent urethral procedures. The retrospective record review should determine the utility of acute urethral realignment after PFUI.
Primary Outcome
Rates of urethral obstruction identified by urethrogram or cystoscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2016-01-01 |
| Est. Completion | 2021-08-31 |
What the finished NCT03195179 record still lists
NCT03195179 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03195179 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03195179 about?
NCT03195179 is a clinical study titled "Primary Urethral Realignment Versus Suprapubic Cystostomy After Pelvic Fracture Urethral Injury". Pelvic fracture urethral injuries (PFUI) occur in up to 10% of pelvic fractures. It remains controversial whether initial urethral realignment after PFUI decreases rates of urethral obstruction and the need for subsequent urethral procedures. The retrospective record review should determine the uti...
What is the current status of trial NCT03195179?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2016-01-01. Estimated completion is 2021-08-31.
Who is sponsoring clinical trial NCT03195179?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI